| Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the … TM Penning, ME Burczynski, JM Jez, CF Hung, HK Lin, H Ma, M Moore, ... Biochemical journal 351 (1), 67-77, 2000 | 662 | 2000 |
| Dihydrodiol Dehydrogenases and Polycyclic Aromatic Hydrocarbon Activation: Generation of Reactive and Redox Active o-Quinones TM Penning, ME Burczynski, CF Hung, KD McCoull, NT Palackal, ... Chemical research in toxicology 12 (1), 1-18, 1999 | 519 | 1999 |
| Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene CH Chen, TL Wang, CF Hung, Y Yang, RA Young, DM Pardoll, TC Wu Cancer research 60 (4), 1035-1042, 2000 | 450 | 2000 |
| Prospects of RNA interference therapy for cancer SI Pai, YY Lin, B Macaes, A Meneshian, CF Hung, TC Wu Gene therapy 13 (6), 464-477, 2006 | 422 | 2006 |
| Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen WF Cheng, CF Hung, CY Chai, KF Hsu, L He, M Ling, TC Wu The Journal of clinical investigation 108 (5), 669-678, 2001 | 331 | 2001 |
| Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype CL Trimble, S Piantadosi, P Gravitt, B Ronnett, E Pizer, A Elko, B Wilgus, ... Clinical cancer research 11 (13), 4717-4723, 2005 | 254 | 2005 |
| Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins TW Kim, CF Hung, M Ling, J Juang, L He, JM Hardwick, S Kumar, TC Wu The Journal of clinical investigation 112 (1), 109-117, 2003 | 225 | 2003 |
| Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe C Trimble, CT Lin, CF Hung, S Pai, J Juang, L He, M Gillison, D Pardoll, ... Vaccine 21 (25-26), 4036-4042, 2003 | 221 | 2003 |
| Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7 … H Ji, TL Wang, CH Chen, SI Pai, CF Hung, KY Lin, RJ Kurman, ... Human gene therapy 10 (17), 2727-2740, 1999 | 214 | 1999 |
| Therapeutic human papillomavirus vaccines: current clinical trials and future directions CF Hung, B Ma, A Monie, SW Tsen, TC Wu Expert opinion on biological therapy 8 (4), 421-439, 2008 | 209 | 2008 |
| A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression AD Bins, A Jorritsma, MC Wolkers, CF Hung, TC Wu, TNM Schumacher, ... Nature medicine 11 (8), 899-904, 2005 | 208 | 2005 |
| Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen CF Hung, WF Cheng, KF Hsu, CY Chai, L He, M Ling, TC Wu Cancer research 61 (9), 3698-3703, 2001 | 195 | 2001 |
| Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus TW Kim, JH Lee, CF Hung, S Peng, R Roden, MC Wang, R Viscidi, ... Journal of virology 78 (9), 4638-4645, 2004 | 191 | 2004 |
| Antigen‐specific immunotherapy of cervical and ovarian cancer CF Hung, TC Wu, A Monie, R Roden Immunological reviews 222 (1), 43-69, 2008 | 173 | 2008 |
| Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22–antigen fusion WF Cheng, CF Hung, KF Hsu, CY Chai, L He, JM Polo, LA Slater, M Ling, ... Human gene therapy 13 (4), 553-568, 2002 | 169 | 2002 |
| Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen WF Cheng, CF Hung, CY Chai, KF Hsu, L He, M Ling, TC Wu Journal of virology 75 (5), 2368-2376, 2001 | 167 | 2001 |
| Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer A Monie, CF Hung, R Roden, TC Wu Biologics: targets & therapy 2 (1), 107, 2008 | 165 | 2008 |
| Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen KF Hsu, CF Hung, WF Cheng, L He, LA Slater, M Ling, TC Wu Gene therapy 8 (5), 376-383, 2001 | 159 | 2001 |
| Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen CF Hung, WF Cheng, CY Chai, KF Hsu, L He, M Ling, TC Wu The Journal of Immunology 166 (9), 5733-5740, 2001 | 155 | 2001 |
| Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6 S Peng, H Ji, C Trimble, L He, YC Tsai, J Yeatermeyer, DAK Boyd, ... Journal of virology 78 (16), 8468-8476, 2004 | 154 | 2004 |
